LANGABEER, S.E.; HASLAM, K.; CRAMPE, M.; MACDONAGH, B.; MCHUGH, J. Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia. Experimental Oncology, [S. l.], v. 41, n. 1, p. 82–83, 2023. DOI: 10.32471/exp-oncology.2312-8852.vol-41-no-1.12685. Disponível em: https://exp-oncology.com.ua/index.php/Exp/article/view/2019-1-1. Acesso em: 19 may. 2025.